Stock News

Amgen and Novartis drop Alzheimer's-prevention study after patients worsened
Amgen, Novartis And Banner Alzheimer's Institute Discontinue Clinical Research Program With BACE Inhibitor CNP520 For Alzheimer's Prevention
Amgen Falls 3%
Amgen, Novartis abandon two Alzheimer’s drug studies

As seen on...